Embryonic stem (ES) cells are self-renewing, pluripotent cell lines, characterized by their potential to differentiate into all cell types. The proto-oncogene product c-Myc has a crucial role in the self-renewal of mouse ES (mES) cells, but its role in human ES (hES) cells is unknown. To investigate c-Myc functions in hES cells, we expressed an inducible c-Myc fused to the hormone-binding domain of the estrogen receptor (c-MycER) protein that is activated by 4-hydroxy-tamoxifen. In contrast to its role in mES cells, activation of c-MycER in hES cells induced apoptosis and differentiation into extraembryonic endoderm and trophectoderm lineages concomitant with reduced expression of the pluripotent markers Oct4 and Nanog. Neither inhibition of caspase activity nor knockdown of p53 by RNA interference impaired the induction of differentiation markers induced by c-Myc activation. In addition, differentiation induced by c-Myc activation was associated with downregulation of a6 integrin expression, suggesting an important role for the integrin/extracellular matrix interaction in the regulation of ES cell behavior. None of these effects occurred with deletion of the c-Myc transactivation domain, indicating that c-Myc promotes both apoptosis and differentiation in a transcriptional activity-dependent manner. Together, our results provide new insights into the c-Myc functions regulating hES cell fate.
Introduction
Human ES (hES) cells are capable of indefinite selfrenewal and appear to have the ability to differentiate into all cell types (Thomson et al., 1998) . Thus, hES cells might provide an essentially unlimited source of specific cells for regenerative medicine, drug screening and an excellent system for studying early human development. Whereas pluripotency of hES cells is maintained in culture with mouse embryonic fibroblasts (MEF), recent studies indicate that fibroblast growth factor 2 (FGF2), a bone morphogenetic protein (BMP) signaling antagonist and transforming growth factor b (TGFb)/activin, or combinations of these factors can support the maintenance of hES cells in an undifferentiated state in the absence of MEF-feeders (Hoffman and Carpenter, 2005; Xu et al., 2005; Yao et al., 2006) . In spite of these recent improvements in cell culture systems, there is little understanding of the regulatory mechanisms that control self-renewal.
The intracellular signaling molecules that are essential for maintaining ES cell self-renewal have been determined to a significant degree of detail, mainly in mouse ES (mES) cells (Boiani and Scholer, 2005) . For example, the critical transcriptional factors Oct4, Sox2 and Nanog have essential roles in maintaining self-renewal and form a regulatory circuitry of autoregulatory and feedforward loops (Boyer et al., 2005) . In addition, mES cell pluripotency is maintained in the presence of leukemia inhibitory factor (LIF), a cytokine that activates the gp130/STAT3-signaling pathway Matsuda et al., 1999) . A recent study demonstrated that the cellular oncogene product c-Myc functions as the key downstream target of STAT3 signaling to support mES cell self-renewal (Cartwright et al., 2005) and plays a crucial role in the reprograming as one of four factors (c-Myc, Oct4, Sox2 and Klf4) that give ES-like pluripotent cells (Takahashi and Yamanaka, 2006) . The requirement of c-Myc for maintaining hES cell self-renewal seems likely, but remains to be established.
c-Myc has critical roles in the regulation of a wide variety of biological processes, including control of cell proliferation, apoptosis, oncogenesis and differentiation (Adhikary and Eilers, 2005) . Deregulated expression of c-Myc promotes proliferation and inhibits a differentiated phenotype in many types of cells such as myeloid and intestinal epithelium (Selvakumaran et al., 1996; Canelles et al., 1997; van de Wetering et al., 2002) . Paradoxically, however, c-Myc activation also induces differentiation of epidermal and hematopoietic stem cells (Gandarillas and Watt, 1997; Wilson et al., 2004) . Thus, c-Myc appears to influence cell behavior, but the relative contribution of each of these pathways depends on the cell type and environment.
To study the effect of c-Myc activation on cell proliferation, apoptosis and differentiation of hES cells, we generated hES cells with an inducible c-Myc estrogen receptor (c-MycER) expression vector that is activated by 4-hydroxy-tamoxifen (4OHT) (Littlewood et al., 1995) . In contrast to the data in mES cells, our results demonstrate that the activation of c-MycER does not support hES cell self-renewal, but rather triggers apoptosis and induces differentiation in a transcriptional activity-dependent manner. Together with previous notions about other stem cell systems, these data suggest that different regulatory mechanisms and cell environments might account for the different consequences of c-Myc function.
Results
Decreased c-Myc expression during hES cell differentiation c-Myc is a key regulator of mES cell self-renewal downstream of the LIF-STAT3 pathway (Cartwright et al., 2005) . To examine the function of c-Myc in hES cell self-renewal, we first analysed its expression in hES cells under various culture conditions. Consistent with previous reports that both FGF2 and MEF-conditioned medium (CM) support hES cells in an undifferentiated state in the absence of a feeder layer (Xu et al., 2001 (Xu et al., , 2005 , hES cell lines, KhES-2 and KhES-3 (Fujioka et al., 2004; Suemori et al., 2006) , were also maintained in their undifferentiated state when the cells were cultured without a feeder layer in CM or media supplemented with FGF2. These cells were in tightly packed colonies with a high nuclear/cytoplasmic ratio, and expressed an undifferentiated ES cell marker, alkaline phosphatase (ALP), whereas cells cultured in non-conditioned medium (non-CM) underwent remarkable differentiation with an enlarged flattened morphology and significantly reduced ALP activity within 5 days ( Figure 1a ). To verify their status, cells were examined by fluorescence-activated cell sorter (FACS) analysis using an anti-Oct4 antibody, a marker of pluripotency. More than 80% of cells cultured in CM or FGF2 had a high level of Oct4 expression, whereas it decreased to 53% at 5 days in the non-CM culture (Figure 1b) . (c) Quantitative real-time PCR analysis of Myc family genes in hES cells. Cells were cultured in CM or non-CM for 5 days without feeder layers and then total RNA was analysed by real-time PCR. The average of normalized ration of target genes/GAPDH was calculated. The data represent the means7s.d. of triplicate experiments. (d) Downregulation of c-Myc protein expression during hES cell differentiation. Cells were cultured under various conditions for 5 days and then cell lysates were subjected to SDS-PAGE, followed by immunoblotting with the corresponding antibodies. Immunoblotting for a-tubulin was used to verify equal loading.
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Western-blot analysis confirmed the high expression levels of Oct4 protein in these culture conditions (Figure 1d ), indicating that the undifferentiated state of KhES-2 and KhES-3 cells could be maintained in CM or FGF2.
Because there are three closely related Myc family genes (MYC, MYCN and MYCL1) that functions in regulation of cellular proliferation, differentiation and apoptosis (Adhikary and Eilers, 2005) , we examined expression levels of these family genes in hES cells. The high expression levels of three Myc family mRNA transcripts were detected in hES cells maintained CM, whereas they were markedly decreased in differentiated cells cultured with non-CM (Figure 1c) . Thus, expression levels of Myc family members coincide with the stem cell state of hES cells. Although overlapping expression patterns among Myc family members raise the possibility of having conserved their functions, it has been reported that the physiological functions of the N-and L-Myc might differ from that of c-Myc (Morgenbesser et al., 1995; Hatton et al., 1996) . Further, we confirmed that the expression level of c-Myc protein was maintained in undifferentiated cells grown in CM or FGF2, whereas it was significantly reduced in differentiated cells that were cultured with non-CM (Figure 1d ). In contrast, the active form of GSK3b (pY216), which negatively regulates c-Myc stability (Sears et al., 2000) and is involved in the regulation of ES cell self-renewal (Sato et al., 2004) , increased in differentiated cells grown in non-CM, but not in undifferentiated cells. These results suggest that the GSK3b/c-Myc signaling pathway might be a key determinant of hES cell self-renewal.
Apoptosis of hES cells induced by sustained c-Myc activation
To examine the role of c-Myc in hES cells, vectors that constitutively express c-MycER, a chimeric protein of c-Myc fused to the hormone binding domain of the mutant estrogen receptor, and its derivatives were introduced into KhES-2 and KhES-3 cells (Figure 2a) . The c-MycER fusion protein can be conditionally activated by the addition of the ER agonist 4OHT (Littlewood et al., 1995) . The deletion mutant c-Myc
ER, which lacks the highly conserved c-Myc Box (MB)-I and MB-II regions, has diminished transcriptional activity and is a biologically inactive form (Stone et al., 1987) . The hES cells were transfected with these expression vectors or empty vectors, and several independent clones with stable expression of the c-MycER fusion proteins were isolated. Expression of cMycER fusion proteins was confirmed by Western-blot analysis using an anti-c-Myc antibody (Figure 2b ). Results presented here were obtained using one or two clones, but similar results were obtained with further independent clones from two different hES cell lines KhES-2 and KhES-3.
Because c-Myc is a key regulator of many cellular processes, such as cell proliferation, apoptosis and differentiation into various cell types (Adhikary and Eilers, 2005) , we first evaluated the effect of sustained c-MycER activation on cell proliferation. To this end, control vector-transfected (vector) and c-MycER-expressed hES cells were cultured in conditions that support self-renewal (i.e., cultured with a feeder layer or in CM without a feeder layer) with or without 4OHT for 5 days, and then analysed by morphological appearance and cell count to score cell proliferation. The addition of 4OHT to control or c-Myc
ER cells had no obvious effect on cell morphology or colony size (Figure 3a) . In contrast, c-MycER cells grown in the presence of 4OHT formed smaller colonies, and exhibited the morphological hallmarks of apoptosis such as a round shape, shrinkage and fragmentation. A proliferation assay demonstrated a twofold decrease in the number of c-MycER cells treated with 4OHT compared with control or c-MycER cells not treated with 4OHT (Figure 3b ). In addition to the growthpromoting activity of c-Myc, elevated c-Myc activity induces apoptosis (Evan et al., 1992) . Thus, these data suggest that sustained c-Myc activation induces apoptosis in hES cells.
To investigate whether sustained c-Myc activity induces apoptosis in hES cells, cells expressing either control vector or c-MycER were treated with 4OHT, and DNA fragmentation was evaluated by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP c-Myc function in human embryonic stem cells T Sumi et al nick end labeling) staining, and apoptosis was quantified by the counting apoptotic nuclei with condensed chromatin. Only a few apoptotic cells were observed among the control cells (vector), in the presence or absence of 4OHT, whereas prominent apoptosis was observed among the 4OHT-treated c-MycER expressing cells ( Figure 4a ). Previous studies demonstrated that a mutation of c-Myc Thr58, which is a GSK3b phosphorylation site, to a nonphosphorylatable amino acid increases c-Myc stability and transforming potential, ER mutant were grown in the presence of 4OHT, however, the cells also displayed increased apoptosis to a similar degree as c-MycER cells (Figure 4b ). Quantitative analyses again revealed a greater than fourfold increase in apoptotic cells in both c-MycER and c-Myc T58A ER cells compared with control cells (Figure 4b ). In contrast, the activation of c-Myc
ER did not induce apoptosis (data not shown), indicating that transcriptional regulation by c-Myc has a critical role in c-Myc-mediated apoptosis of hES cells. Collectively, these data indicate that sustained c-Myc activation promotes apoptosis in hES cells.
Activation of c-Myc upregulates cyclin A1 and D2 expression in hES cells c-Myc has been implicated in regulating multiple genes involved in cell survival and proliferation (Adhikary and Eilers, 2005) . To determine whether c-Myc could regulate both cell survival and proliferation-related genes in hES cells, cells expressing either vector or c-MycER were treated with 4OHT, and reverse transcriptionpolymerase chain reaction (RT-PCR) analysis for genes regulatable by c-Myc was performed. As shown, c-Myc specifically activates transcription of cyclin A1 (CCNA1) and D2 (CCND2), whereas transcripts of cdk2 (CDK2), cdk4 (CDK4) and cyclin D1 (CCND1) were unchanged ( Figure 5a ). Furthermore, c-Myc-induced apoptosis appeared independent to the well-established ability of c-Myc to repress Bcl2 family genes (Maclean et al., 2003) , because no consistent effect of c-Myc on expression of Bcl2 (BCL2), Bcl-xL (BCL2L1) and Mcl1 (MCL1) transcripts was observed in hES cells ( Figure 5b ). Treatment of 4OHT slightly, but c-Myc independently, affected Bcl2 expression in cells expressing either control vector or c-MycER, because estrogen has been shown to be capable of regulating Bcl2 expression (Leung and Wang, 1999) . Thus, these data show that sustained activation of c-Myc upregulates some cell cycle regulators but not anti-apoptotic regulators in hES cells, and suggest that induction of cyclin family genes might not be sufficient to promote hES cell proliferation.
Differentiation of hES cells induced by sustained c-Myc activation
Because c-Myc inhibits cell differentiation in a variety of cell types and has a role in mES cell pluripotency (Selvakumaran et al., 1996; Canelles et al., 1997; van de Wetering et al., 2002; Cartwright et al., 2005) , we next asked whether sustained c-Myc activation could also support self-renewal in hES cells under feeder-free culture conditions. c-MycER-expressing hES cells were grown in non-CM in the presence or absence of 4OHT for 5 days, and then the undifferentiated state was monitored both by morphological appearance and by determining the amount of the undifferentiated ES cell marker, ALP. In contrast to its role in mES cells, c-Myc-activated hES cells treated with 4OHT had a rapid loss of ALP expression compared with control cells grown with CM or c-MycER cells not treated with 4OHT ( Figure 6a ). Similar data were obtained in another hES cell line, KhES-3. Thus, these results show that under feeder-free culture conditions, sustained cMyc activation in hES cells might accelerate cell differentiation rather than support their undifferentiated state.
To examine further whether sustained c-Myc activation induces cell differentiation in hES cells, cells were maintained with CM in the presence or absence of 4OHT for 5 days, and then the cell population expressing pluripotency marker Oct4 was determined by flow cytometry (Figure 6b ). In the absence of 4OHT, c-MycER cells had no obvious effect on Oct4 expression compared with control cells. In contrast, Oct4 was These data indicate that sustained c-Myc activation induces downregulation of Oct4 in a transcriptional activity-dependent manner, even in culture conditions that maintain the undifferentiated state.
To address whether downregulation of Oct4 by c-Myc evokes cell differentiation, cells expressing c-MycER were activated by 4OHT for 5 days, and used for RT-PCR analysis. The expression of mRNAs encoding pluripotent-associated genes OCT4 and NANOG were slightly, but consistently, downregulated by sustained activation of both c-MycER and c-Myc T58A ER compared to control cells (Figure 6c) . Intriguingly, consistent with previous reports that loss of function of Oct4 and Nanog induces cell differentiation toward trophectoderm and extraembryonic endoderm lineages, respectively (Nichols et al., 1998; Chambers et al., 2003; Mitsui et al., 2003) , sustained activation of c-MycER and c-Myc T58A ER significantly induced both extraembryonic endoderm genes (GATA4 and GATA6) and trophectoderm genes (CDX2 and CGA (chorionic gonadotropin-a)). These results indicate that the sustained c-Myc activation induces hES cells to form extraembryonic endoderm and trophectoderm lineages, rather than maintaining hES cells in an undifferentiated state.
Apoptotic-and p53-independent differentiation of hES cells induced by c-Myc activation
Apoptosis is a process of caspase-mediated cell death and is critical for the normal development and function of multicellular organisms (Strasser et al., 2000) . Caspase activity contributes significantly to controlling cell differentiation in several cell types such as erythrocytes, skeletal muscle cells and neural stem cells (Zermati et al., 2001; Fernando et al., 2002 Fernando et al., , 2005 Okuyama et al., 2004) . Because c-Myc induces apoptosis via the activation of caspase, and the absence of caspase and p53 attenuates c-Myc-induced apoptosis (Soengas et al., 1999) , c-Myc-evoked apoptotic signals might contribute to the commitment of hES cells to differentiate. To confirm the contribution of caspase-like proteases to c-Myc-mediated differentiation, we treated hES cells expressing c-MycER with Z-DEVD-FMK, a specific inhibitor of caspase-3-like proteases. TUNEL staining showed that induction of c-Myc-mediated apoptotic cell death was effectively prevented by the caspase inhibitor (Figure 7a ), indicating that (Figure 7b ). These data indicate that c-Myc induces hES cell differentiation in a caspase-mediated apoptotic program-independent manner. This conclusion is also supported by the previous finding that enforced expression of Bcl-2, an anti-apoptotic protein, did not affect mES cell differentiation (Yamane et al., 2005) .
c-Myc activates the Arf-p53 tumor suppressor pathway and induces p53-dependent and -independent apoptosis or cell cycle arrest (Zindy et al., 1998; Juin et al., 1999) . In mES cell, p53 is crucial for cell death accompanying differentiation or differentiation of DNA-damaged ES cells by directly suppressing Nanog expression (Lin et al., 2005) . In addition, p53 and its downstream target p21 CIP1/WAF1 are implicated in the selfrenewal of several types of stem cells (Cheng et al., 2000; Kippin et al., 2005; Meletis et al., 2006) . Thus, we hypothesized that c-Myc-mediated p53 signals might contribute to the commitment of hES cells to differentiate. To this end, we first determined whether the activation of c-Myc induces the p53-p21 CIP1/WAF1 pathway in hES cells. Immunoblot analysis confirmed that the expression of p53 and its downstream target p21 CIP1/ WAF1 were induced at higher levels in c-Myc T58A ER than in control cells when cells were treated with 4OHT ( Figure 8a ). To elucidate the involvement of the p53 pathway in c-Myc-induced hES cell differentiation, we used RNA interference to study p53 loss of function in c-Myc-mediated differentiation. Consistent with previous report (Brummelkamp et al., 2002) , transient transfection of plasmids expressing both green fluorescent protein (GFP) and small hairpin RNA (shRNA) targeting p53 resulted in a reduction in p53 expression levels in GFP-positive cells, indicating that this vector can suppress endogenous p53 expression in hES cells (Figure 8b ). To determine whether the suppression of p53 expression affects c-Myc-induced differentiation of hES cells, we constructed RNAi vectors containing a puromycin selection cassette and transfected these vectors into hES cells. Two-days after transfection, cells were selected with puromycin for 3 days to enrich cells received the vector because of lower transfection efficiency of hES cells. Total RNA, was purified from these transfected cells, and the levels of the transcripts for p53 (TP53) and differentiated cell markers were assessed by RT-PCR analysis. We observed more than 60% reduction of TP53 transcripts in the sh-p53-transfected cells relative to the control cells (Figure 8c ). When empty vector-transfected cells were stimulated with 4OHT, the expression of differentiationrelated genes was upregulated (Figure 8c) . Transfection of the plasmid for sh-p53 in hES cells, however, had no apparent effect on the expression of differentiationrelated genes. Similar results were obtained with an additional nonoverlapping shRNA construct reported previously to knockdown p53 expression (Berns et al., 2004) (Figure 8c ). These results indicate that p53-independent c-Myc-evoked pathways might contribute to hES cell differentiation. 
Repression of cell-adhesion molecule by sustained c-Myc activation
Previous studies demonstrated that c-Myc functions to promote differentiation by disrupting adhesive interactions between stem cells and their niche (Gandarillas and Watt, 1997; Frye et al., 2003; Wilson et al., 2004) . In addition, laminin-specific receptors (such as integrin a6 and b1) are highly expressed in ES cells, suggesting that laminin-specific receptor(s) might be important cell surface factors for the maintenance of undifferentiated hES cells (Czyz and Wobus, 2001; Xu et al., 2001) . To investigate whether c-Myc activation decreases the expression of adhesive molecules, flow cytometry was performed on 4OHT-treated c-MycER-expressing hES cells ( Figure 9 ). As reported previously in other stem cell systems (Gandarillas and Watt, 1997; Frye et al., 2003; Wilson et al., 2004) , cell surface levels of integrin a6 in hES cells decreased upon activation of c-MycER treated with 4OHT, whereas this did not occur in control or inactive c-MycER-expressing cells. Thus, these data suggest that the reduced expression of integrin a6 by c-Myc activation, which is involved in the interactions between hES cells and the extracellular matrix (ECM), might stimulate an exit from the undifferentiated state.
Discussion
The present study provides the first evidence that constitutive c-Myc activation in hES cells leads to both apoptosis and differentiation rather than to the maintenance of self-renewal. This differentiation is accompanied by a reduced expression of Oct4 and Nanog, which are key transcription factors for pluripotency, and induced expression of extraembryonic endoderm and trophectoderm markers. In addition, hES cell differentiation by c-Myc activation was associated with the downregulation of the a6 integrin subunit, suggesting an important role for the integrin/ECM interaction in the regulation of hES cell behavior. Unexpectedly, these data are in contrast to the crucial roles established for c-Myc in mES cells (Cartwright et al., 2005) , but they are consistent with the concept that c-Myc has a role in determining the balance between stem cell self-renewal . Cells were cultured with or without 4OHT for 5 days and then cell lysates were subjected to SDS-PAGE, followed by immunoblotting with the corresponding antibodies. Immunoblotting for a-tubulin was used to verify equal loading. (b) RNA interference of p53. Cells were transfected with plasmid expressing both GFP and short-hairpin RNA targeting p53 (sh-p53). After 3 days, cells were fixed and stained with anti-GFP and anti-p53 antibodies. (c) Effect of p53 inhibition by RNA interference on the c-Myc-induced differentiation. Cells expressing c-MycER were transfected with plasmid encoding either empty vector or sh-p53 (#1 or #2) with or without 4OHT. Two days after transfection, cells were selected with puromycin (1 mg/ml) for 3 days, and analysed by RT-PCR with primers corresponding to the indicated genes. Two independent c-MycER lines are shown. Figure 9 Flow-cytometric analysis of hES cells labeled with antibody against the a6 integrin subunit. Cells expressing either empty vector, c-MycER, or its mutant were cultured with or without 4OHT for 5 days, and then stained with a6 integrin.
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and differentiation depending on cell type and environment (Gandarillas and Watt, 1997; Wilson et al., 2004) .
Self-renewal of undifferentiated ES cells requires signals maintaining the balance between cell proliferation and the inhibition of apoptosis as well as differentiation (Duval et al., 2006) . Recent report showed that expression levels of some pro-and anti-apoptotic genes including caspase-3, NF-kB and calpains were changed during hES cell differentiation toward trophoblast using OCT4 RNAi (Babaie et al., 2007) . Although expression of anti-apoptotic genes such as Bcl2, BclxL and Mcl1 were not changed in c-Myc-induced differentiation, other apoptotic-related genes might be regulated by c-Myc. c-Myc promotes both proliferation and apoptosis via p53-dependent and -independent pathways (Zindy et al., 1998; Juin et al., 1999) . In oncogenic transformation, c-Myc functionally cooperates with mutations that disable apoptotic programs or with several genes such as oncogenes and polycomb genes (Adhikary and Eilers, 2005) . Some of the c-Myc target genes and its collaborative genes were implicated recently in stem cell function. For example, the tumor suppressor p53, which is induced by c-Myc, and the polycomb protein Bmi-1 control cell proliferation and maintenance of self-renewal in several types of stem cells (Molofsky et al., 2003; Park et al., 2003; Meletis et al., 2006) . In addition, cyclin-dependent kinase inhibitors such as CIP/KIP and INK4 participate in controlling hematopoietic stem cells and neural stem cells (Cheng et al., 2000; Yuan et al., 2004; Kippin et al., 2005; Nguyen et al., 2006) . Moreover, the activation of p53 induces the differentiation of DNA-damaged mES cells as a consequence of direct suppression of Nanog expression (Lin et al., 2005) . These reports suggest that common signaling pathways are involved in the maintenance of self-renewal in these cell types. We found that sustained activation of c-Myc resulted in elevated levels of the p53-p21 CIP1/WAF1 tumor-suppressor pathway in hES cells. Although activation of the p53-p21
pathway is a key downstream event of c-Myc-induced cell cycle arrest and apoptosis, neither inhibition of caspase activity nor knockdown of p53 by RNA interference in c-Myc-activated hES cells affected the induction of differentiation markers evoked by c-Myc, compared with controls. Thus, c-Myc-induced differentiation of hES cells relies on other intrinsic pathways and occurs in a p53-independent and caspase-mediated apoptotic program-independent manner.
We also found that c-Myc activation induced downregulation of the a6 integrin subunit, suggesting the involvement of integrin signaling in maintaining hES cells in an undifferentiated state. Integrin ECM receptors and other cell adhesion molecules regulate cell growth, survival and differentiation in many cell types (Hynes, 2002) . Previous studies indicated that c-Myc activation downregulates cell adhesion molecules, including a range of integrin subunits, in epidermal and hematopoietic stem cells (Gandarillas and Watt, 1997; Wilson et al., 2004) , and c-Myc can act directly on the promoter of gene-encoded components of the ECM, integrins and other cell adhesion molecules, and reduce cell-ECM adhesion (Frye et al., 2003; Gebhardt et al., 2006) . Reduced cell-ECM adhesion stimulates the exit from the stem cell compartment and promotes differentiation (Gandarillas and Watt, 1997; Wilson et al., 2004) . Although detachment from the basement membrane and loss of integrin contacts is a potent apoptotic stimulus in most cells (Miner and Yurchenco, 2004) , when ES cells are placed in suspension to form embryoid bodies, they immediately undergo differentiation into any of three germ layers (Evans and Kaufman, 1981; Martin, 1981) . In addition, because laminin receptors such as a6b1 and a6b4 are highly expressed in mouse and hES cells (Czyz and Wobus, 2001; Xu et al., 2001) , they are thought to be important for maintaining ES cells in an undifferentiated ES cells. Therefore, our present data suggest that c-Myc promotes the exit from the stem cell self-renewal state by reducing cell-ECM adhesion, and might provide new insights into how integrins regulate pluripotency of hES cells.
The reasons for the different functions of c-Myc in maintaining pluripotency between mouse and hES cells are not yet clear, but several lines of evidence suggest significant species-specific differences for the maintenance of pluripotency. The LIF/STAT3 and BMPs pathways, which are sufficient to support mES cell selfrenewal Ying et al., 2003) , do not support hES cell self-renewal (Xu et al., 2002 (Xu et al., , 2005 Humphrey et al., 2004) . In contrast to mES cells, the FGF2 signaling pathway is of central importance to hES cell self-renewal (Xu et al., 2005) . While crucial transcriptional factors such as Nanog and Oct4 have conserved roles in maintaining pluripotency (Hay et al., 2004; Hyslop et al., 2005) , the limited overlap of their transcriptional targets between mouse and human suggests species-specific differences in the networks for Oct4-and Nanog-regulated self-renewal. Thus, we suggest that subtle differences in the c-Myc target genes expressed in various cell types might give rise to the different outcomes. Future studies are required to clarify this notion.
In summary, we conclude that in contrast to its roles in mES cells, c-Myc promotes both apoptosis and differentiation in hES cells, but does not support selfrenewal. Thus, the precise roles of c-Myc appear to be dependent on cell type and environment. The involvement of c-Myc in stem cell behavior indicates that c-Myc has a role in the regulatory network of the global stem cell system. The identification of c-Myc target genes in hES cells will facilitate our understanding of the control of hES cell behavior.
Materials and methods

Cell culture
The hES cell lines KhES-2 and KhES-3 were maintained as described previously (Fujioka et al., 2004; Suemori et al., 2006) . Briefly, cells were dissociated into small clumps and cultured on feeder layers of MEF that were mitotically inactivated with mitomycin C. Cells were cultured in the hES cell medium consisting of Dulbecco's modified Eagle's medium/F12 (Sigma Chemical Co., St Louis, MO, USA), c-Myc function in human embryonic stem cells T Sumi et al 20% knockout serum replacement (Invitrogen, Carlsbad, CA, USA), 0.1 mM 2-mercaptoethanol (Sigma), MEM nonessential amino acids (Sigma), 2 mM L-glutamine (Sigma) and 5 ng/ml of FGF2 (Upstate Biotechnology, Lake Placid, NY, USA). For the preparation of CM, the hES cell medium was conditioned by incubating 10 ml of medium with 5 ng/ml FGF2 for 24 h on mitotically inactivated MEF culture (5 Â 10 6 cells/100-mm diameter dish). CM was collected for 4 days and stored at À301C until it was used.
For feeder-free culture, hES cells were dissociated into small clumps and cultured on plates coated with Matrigel (BD Biosciences, San Jose, CA, USA) in CM or non-CM with or without 20 ng/ml FGF2 for 5 days.
Cell lines expressing c-MycER and their derivatives were obtained by transfection of hES cells with c-MycER expression plasmids, followed by neomycin selection as described previously (Sumi et al., 2004) . Neomycin-resistant clones were isolated, and the expression of c-MycER proteins was confirmed by immunoblotting. For analysis of cell growth, 2 Â 10 4 cells were seeded onto 60-mm dishes in CM without a feeder layer. The next day, the medium was replaced with CM with or without 4OHT, and the number of cells was counted after 5 days of treatment. Activation of c-MycER was induced by the addition of 200 nM 4OHT (Sigma) to the medium for the indicated time periods. Caspase activity was blocked by treatment with 40 mM Z-DEVD-FMK peptide inhibitor (R&D Systems, Minneapolis, MN, USA) for 5 days in the presence of 200 nM 4OHT.
Plasmid construction
To generate a plasmid encoding c-Myc, full-length human cMyc cDNA was cloned by RT-PCR using the following primers: forward, 5 0 -ACGATGCCCCTCAACGTTAG-3 0 ; and reverse, 5 0 -CCTTACGCACAAGAGTTCCG-3 0 . The PCR product was ligated into a pGEM-T vector (Promega, Madison, WI, USA). For the construction of c-MycER, PCR was used to add XhoI/EcoRI sites immediately upstream of the ATG of a human c-Myc cDNA, and to delete the stop codon and add an XhoI site to allow in-frame fusion with the ER. The c-Myc T58A mutant was constructed by Thr58 with Ala using the GeneEditor in vitro Site-Directed Mutagenesis System (Promega). The c-Myc D40-178 mutant was generated by deletion of a PstI fragment (a.a. 40-178 of c-Myc). An XhoI-SalI fragment containing a mutant ER cDNA from the vector pCreER T2 (a gift from Pierre Chambon) was ligated into a pBSSK(À) vector. An XhoI fragment containing c-Myc cDNA was inserted in an XhoI site of the pBSSK(À)-ER. An EcoRI fragment containing c-MycER was ligated to an EcoRIdigested pCAG/PGKneo vector (Sumi et al., 2004) . The expression vector pCAG-GiP was constructed by inserting the enhanced GFP and internal ribosome entry site (IRES) sequences, followed by the puromycin-resistance gene, into the pCAGGS vector. The plasmid pCAG-GiP/H1-sh-p53 was constructed by inserting the H1 promoter (pSilencer 3.0-H1, Ambion, Foster City, CA, USA) and p53 targeting sequence. The targeting sequences were sh-p53#1: 5 0 -GACTC-CAGTGGTAATCTAC-3 0 , sh-p53#2: 5 0 -CTACATGTGTAA-CAGTTCC-3 0 , as described previously (Brummelkamp et al., 2002; Berns et al., 2004) . All constructs were confirmed by nucleotide sequence analysis.
RNA interference ES cells expressing c-MycER were cultured with CM in the presence or absence of 4OHT (200 nM), and were transiently transfected with pCAG-GiP/H1-shp53 construct or an empty vector using FuGENE HD (Roche Applied Science, Indianapolis, IN, USA) transfection reagent. Two days after transfection, cells were selected with puromycin (1 mg/ml) for 3 days, and then harvested for RNA preparation.
Immunoblot analysis ES cells were lysed with buffer consisting of 50 mM Tris-HCl (pH 7.5), 0.3 M NaCl, 25 mM b-glycerophosphate, 10 mM NaF, 1 mM Na 3 VO 4 , 1% Triton X-100, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 2 mg/ml leupeptin and aprotinin. After centrifugation, the supernatants were dissolved in the sample buffer for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Cell lysates were separated by SDS-PAGE, electroblotted onto a polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA, USA) and probed with primary antibodies. After incubation with horseradish peroxidase-conjugated secondary antibody (DakoCytomation, Glostrup, Denmark), proteins reacting with the different antibodies were detected using Western Blotting Luminol Reagent (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Antibodies against the following proteins were used: c-Myc (#9402) and p21Waf1/Cip1(#2946) (Cell Signaling Technology, Beverly, MA, USA), Oct-3/4 (C-10) and p53 (DO-1) (Santa Cruz Biotechnology), a-tubulin (DM1A) (Sigma), phospho-GSK3b (pY216) and GSK3b (BD Biosciences) and GFP (Invitrogen).
Quantitative and semi-quantitative PCR analysis
The hES cell clones expressing c-MycER constructs were grown with or without 200 nM 4OHT for the indicated time periods, and total RNA was isolated using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. RNA samples (2 mg) were reversetranscribed with Omniscript RT Kit (Qiagen). For semi-quantitative PCR, PCRs were optimized to allow semi-quantitative comparisons within the log phase of amplification. For quantitative PCR, PCRs were run in triplicate using 1/10th of the cDNA per reaction and 500 nM forward and reverse primers with the SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). Alternatively, TaqMan gene expression assays were used according to the manufacturer's instructions (Applied Biosystems). Real-time PCR was performed using the ABI 7500 Real-time PCR system (Applied Biosystems). The relative quantification of each gene was performed against a standard curve and quantified values were normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The list of gene-specific primers, annealing temperatures are shown in Table 1 .
Immunocytochemical and immunofluorescence analysis ES cells were fixed with 3.7% formaldehyde in phosphatebuffered saline (PBS) for 20 min. After washing with PBS, ALP activity was detected with Vector Blue substrate (Vector Laboratories, Burlingame, CA, USA). For immunofluorescence, fixed cells were also treated with 100% methanol for 5 min at À201C or 0.2% Triton X-100 in PBS for 5 min at room temperature. After blocking with PBS containing 2% bovine serum albumin and 3% normal goat serum for 30 min, the cells were incubated with primary antibodies for 1 h, followed by incubation with secondary antibodies. Alexa Fluor 488-or 546-conjugated secondary antibodies were purchased from Invitrogen (Carlsbad, CA, USA). Nuclei were counterstained with 4 0 , 6-diamidino-2-phenylindole (DAPI). Cells were washed three times with PBS, mounted on glass slides, and then analysed using an LSM510 confocal laserscanning microscope (Carl Zeiss, Oberkochen, Germany). 
Analysis of apoptotic morphology
For analysis of apoptotic cells, cells were seeded onto 35-mm dishes, and treated as described above. After trypsinization, cells were fixed in 3.7% formaldehyde in PBS for 30 min at room temperature, and nuclei were stained with 1 mg/ml Hoechst 33342 (Invitrogen) for 10 min and examined by fluorescence microscopy following UV illumination. Apoptotic cells were scored for changes in nuclear morphology. Apoptotic values were calculated as the number of apoptotic cells relative to the total number of cells in random fields (>500 cells/sample) and represent the average of three independent experiments7the standard deviation (s.d.) of the mean.
For TUNEL staining, cells were fixed in 1.0% formaldehyde in PBS for 30 min at 41C, and washed twice in PBS and tested for evidence of apoptosis by TUNEL according to the manufacturer's instructions (DeadEnd Fluorometric TUNEL System, Promega). At the end of the assay, slides were washed, covered and examined by fluorescence microscopy. Nuclei were counterstained with DAPI.
FACS analysis
Single cell suspensions of cultured hES cells were fixed with 1% formaldehyde and permeabilized with 70% ethanol for Oct4 staining. Cells were incubated with primary antibody against the Oct4 or the a6 integrin subunit (GoH3) and subsequently with Alexa Fluor 488-conjugated secondary antibody directed against mouse or rat IgG (Invitrogen). FACS analysis was performed using a FACSCalibur Flow Cytometer (Becton Dickinson, Franklin, NJ, USA), and data were analysed using CellQuest software (Becton Dickinson). c-Myc function in human embryonic stem cells T Sumi et al
